Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
Targeted interventions could help reduce pre-test anxiety, improve the physical screening experience, and address structural barriers in underserved settings.
Widaplik, the new polypill from George Medicines, includes telmisartan, amlodipine and indapamide. The FDA's decision comes after positive data were published in both JACC and The Lancet.
Consulting firm Vizient is forecasting continued growth in the specialty, driven by shifts in where patients receive care, new therapies that require imaging and a rapidly aging population.
This new guidance emphasizes that clinical and operational decisions must “remain in the ultimate control” of radiologists or other clinicians, the AMA said Monday.
Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
![Performing transcatheter aortic valve replacement (TAVR) with the J-Valve transcatheter heart valve (THV) may help limit the risk of coronary artery obstruction (CAO) in high-risk patients, according to a new study published in Clinical Interventions in Aging.[1]](/sites/default/files/styles/stack_views/public/2024-10/screenshot_2024-10-01_at_2.16.21_pm.png.webp?itok=qOxNPyOr)
